Search

Your search keyword '"Dejana, Elisabetta"' showing total 1,219 results

Search Constraints

Start Over You searched for: Author "Dejana, Elisabetta" Remove constraint Author: "Dejana, Elisabetta"
1,219 results on '"Dejana, Elisabetta"'

Search Results

1. GPR126 is a specifier of blood-brain barrier formation in the mouse central nervous system

2. Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study

3. Circulating biomarkers in familial cerebral cavernous malformation

4. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies

5. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

6. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation

7. Correction: Inflammation and neutrophil extracellular traps in cerebral cavernous malformation

10. Inflammation and neutrophil extracellular traps in cerebral cavernous malformation

12. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function

13. Progesterone Receptor in the Vascular Endothelium Triggers Physiological Uterine Permeability Preimplantation

16. Sox17 is indispensable for acquisition and maintenance of arterial identity

17. Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study

18. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo.

25. Functionally specialized junctions between endothelial cells of lymphatic vessels

26. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function

28. CD93 promotes [[beta].sub.1] integrin activation and fibronectin fibrillogenesis during tumor angiogenesis

33. FigS1,FigS2,FigS3,FigS4,FigS5,FigS6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy

34. Supplemental figures 1-6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy

35. Data from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy

36. Table and material & methods from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy

37. Supplementary Figure 4 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

38. Supplementary Figure 5 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

39. Data from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

40. Supplementary Figure 1 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

41. Supplementary Methods, Figure Legends 1-5 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

42. Supplementary Figure 2 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

43. Supplementary Figure 3 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

46. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin

Catalog

Books, media, physical & digital resources